[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=ABCL #%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]

[iframe https://api.stockdio.com/visualization/financial/charts/v1/PricesChange?app-key=F086EEE750E14D8D8A456DB88B2D6D8C&symbol=ABCL &conditionalVolume=false&allowPeriodChange=false&tooltipsStyle=None&palette=Financial-Light&showBorderAndTitle=false 300 200 ]

Float Short %

23.61

Margin Of Safety %

Put/Call OI Ratio

0.16

EPS Next Q Diff

EPS Last/This Y

-0.1

EPS This/Next Y

-0.04

Price

3.59

Target Price

9.83

Analyst Recom

1.25

Performance Q

-15.33

Relative Volume

0.49

Beta

0.73

Ticker: ABCL

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2025-11-10	ABCL	4.03	0.19	0.01	107009
2025-11-11	ABCL	4	0.17	0.10	119268
2025-11-12	ABCL	3.95	0.17	3.29	118915
2025-11-13	ABCL	3.61	0.17	0.16	118541
2025-11-14	ABCL	3.7	0.17	0.35	117803
2025-11-17	ABCL	3.59	0.17	0.08	118298
2025-11-18	ABCL	3.67	0.17	0.35	118634
2025-11-19	ABCL	3.62	0.14	0.35	117631
2025-11-20	ABCL	3.39	0.14	0.12	117215
2025-11-21	ABCL	3.51	0.13	0.12	116321
2025-11-24	ABCL	3.58	0.12	0.12	101823
2025-11-25	ABCL	3.63	0.12	0.19	102652
2025-11-26	ABCL	3.63	0.12	1.80	102917
2025-12-01	ABCL	3.45	0.16	0.08	106981
2025-12-02	ABCL	3.47	0.16	0.11	106901
2025-12-03	ABCL	3.49	0.16	0.01	108014
2025-12-04	ABCL	3.66	0.16	0.11	108284
2025-12-05	ABCL	3.57	0.16	0.51	109400
2025-12-08	ABCL	3.6	0.16	0.08	109997
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-11-10	ABCL	4.03	4.7	-	-0.60
2025-11-11	ABCL	4.01	4.7	-	-0.66
2025-11-12	ABCL	3.95	4.7	-	-0.66
2025-11-13	ABCL	3.60	4.7	-	-0.66
2025-11-14	ABCL	3.70	-83.3	-	-0.66
2025-11-17	ABCL	3.60	-43.3	-	-0.64
2025-11-18	ABCL	3.66	-43.3	-	-0.64
2025-11-19	ABCL	3.61	-43.3	-	-0.64
2025-11-20	ABCL	3.39	-43.3	-	-0.64
2025-11-21	ABCL	3.51	-45.8	-	-0.64
2025-11-24	ABCL	3.57	-45.8	-	-0.64
2025-11-25	ABCL	3.62	-45.8	-	-0.65
2025-11-26	ABCL	3.63	-45.8	-	-0.65
2025-12-01	ABCL	3.46	-58.3	-	-0.65
2025-12-02	ABCL	3.46	-58.3	-	-0.65
2025-12-03	ABCL	3.49	-58.3	-	-0.65
2025-12-04	ABCL	3.66	-58.3	-	-0.65
2025-12-05	ABCL	3.56	-58.3	-	-0.65
2025-12-08	ABCL	3.59	-58.3	-	-0.65
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

19 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-11-10	ABCL	0.00	-9.33	23.56
2025-11-11	ABCL	0.00	-9.33	23.56
2025-11-12	ABCL	0.00	-9.33	24.43
2025-11-13	ABCL	0.00	-9.33	24.34
2025-11-14	ABCL	0.00	-9.33	24.34
2025-11-17	ABCL	0.00	-1.01	24.34
2025-11-18	ABCL	0.00	-1.01	24.34
2025-11-19	ABCL	0.00	-1.01	24.34
2025-11-20	ABCL	0.00	-1.01	24.34
2025-11-21	ABCL	0.00	-1.01	23.91
2025-11-24	ABCL	0.00	-1.78	23.91
2025-11-25	ABCL	0.00	-1.78	23.91
2025-11-26	ABCL	0.00	-1.78	23.60
2025-12-01	ABCL	0.00	-1.77	23.61
2025-12-02	ABCL	0.00	-1.77	23.61
2025-12-03	ABCL	0.00	-1.77	23.61
2025-12-04	ABCL	0.00	-1.77	23.61
2025-12-05	ABCL	0.00	-1.77	23.61
2025-12-08	ABCL	0.00	-1.78	23.61
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

19 items 1 of 1

[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=ABCL 589 360 ]

Last Quarter Act. EPS

-0.19

Avg. EPS Est. Current Quarter

-0.19

Avg. EPS Est. Next Quarter

-0.18

Insider Transactions

Institutional Transactions

-1.78

Beta

0.73

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

9.83

P/E

Forward P/E

PEG

P/S

30.42

P/B

1.11

P/Free Cash Flow

EPS

-0.58

Average EPS Est. Cur. Y

-0.65

EPS Next Y. (Est.)

-0.69

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-486.01

Relative Volume

0.49

Return on Equity vs Sector %

-44.7

Return on Equity vs Industry %

-29.8

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.05

EBIT Estimation

[iframe https://widget.finnhub.io/widgets/recommendation?symbol=ABCL 589 450 ]

[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=ABCL 589 450 ]

AbCellera Biologics Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 596

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.

stock quote shares ABCL – AbCellera Biologics Inc. Stock Price stock today

news today ABCL – AbCellera Biologics Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ABCL – AbCellera Biologics Inc. yahoo finance google finance

stock history ABCL – AbCellera Biologics Inc. invest stock market

stock prices ABCL premarket after hours

ticker ABCL fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: ABCL

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y